发明授权
- 专利标题： Ophthalmic compositions for treating ocular hypertension
- 专利标题（中）： 用于治疗高眼压症的眼用组合物
-
申请号： US10530840申请日： 2003-11-04
-
公开(公告)号： US07528163B2公开(公告)日： 2009-05-05
- 发明人: James B. Doherty , Meng-Hsin Chen , Luping Liu , Swaminathan R. Natarajan , Dong-Ming Shen , Robert M. Tynebor
- 申请人： James B. Doherty , Meng-Hsin Chen , Luping Liu , Swaminathan R. Natarajan , Dong-Ming Shen , Robert M. Tynebor
- 申请人地址： US NJ Rahway
- 专利权人： Merck & Co. Inc.
- 当前专利权人： Merck & Co. Inc.
- 当前专利权人地址： US NJ Rahway
- 代理商 Sylvia A. Ayler; William Krovatin
- 国际申请： PCT/US03/34959 WO 20031104
- 国际公布： WO2004/043354 WO 20040527
- 主分类号： A61K31/415
- IPC分类号： A61K31/415 ; C07D231/56
摘要：
This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraocular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
公开/授权文献
- US20060020000A1 Ophthalmic compositions for treating ocular hypertension 公开/授权日：2006-01-26
信息查询
